Impact of BREXIT on UK Gene and Cell Therapy: The Need for Continued Pan-European Collaboration. (2016)
Attributed to:
Development of an AAV vector for treatment of inherited retinal dystrophy caused by RPE65 deficiency
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1089/hum.2016.29033.ahb
PubMed Identifier: 27622542
Publication URI: http://europepmc.org/abstract/MED/27622542
Type: Journal Article/Review
Volume: 27
Parent Publication: Human gene therapy
Issue: 9
ISSN: 1043-0342